News & Updates

A non–risk-based screening approach for hepatitis C virus (HCV) infection in the emergency department (ED), where all eligible patients were offered rapid testing, improves the identification of new infections when compared with a targeted approach of narrowly focusing on at-risk groups, according to the DETECT Hep C trial.

Tumour treating fields (TTFields) added to first-line chemotherapy (gemcitabine and nab-paclitaxel [GnP]) extends survival in individuals with locally advanced pancreatic adenocarcinoma (LA-PAC) in the PANOVA-3 study.